Skip to content

Strength for U in Relationship Empowerment

Computerized Intervention for Reducing Intimate Partner Violence for Perinatal Women Seeking Mental Health Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04218864
Acronym
SURE
Enrollment
122
Registered
2020-01-06
Start date
2020-01-02
Completion date
2024-02-09
Last updated
2025-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IPV, Mental Health, Perinatal

Brief summary

The objective of this study is to test whether the innovative intervention, Strength for U in Relationship Empowerment (SURE), reduces the frequency of IPV more than an attention, time, and information matched control condition in perinatal women seeking mental health care.

Detailed description

Intimate partner victimization (IPV) is a significant social and public health problem among perinatal women. IPV places a woman at high risk for several psychiatric disorders, which transforms the perinatal period from an already challenging process into a potentially overwhelming one. IPV and untreated mental illness during the perinatal period poses a dual risk of adverse physical and emotional outcomes for women and their developing fetus/infant. Given the high rates of IPV among women who seek mental health treatment, mental health clinics compared to other medical settings (e.g. primary care) are more effective sites for focused case finding and intervention. In addition, the presence of IPV increases the likelihood of disengagement from treatment, which could further compromise the health and safety of women and their fetus/infant. Despite the high-risk profile of women with IPV and mental health illness, there are low screening and intervention rates of female mental health patients with IPV within mental health settings. The objective of this R01 Award is to fill this critical gap by building upon our promising pilot findings to test whether the innovative intervention, Strength for U in Relationship Empowerment (SURE), reduces the frequency of IPV more than an attention, time, and information matched control condition in perinatal women seeking mental health care. The investigators propose a two-group, randomized controlled trial in which 186 perinatal women with IPV women seeking mental health care who will be assigned to either (a) SURE, a computer-delivered, single-session brief intervention plus one interventionist-led phone booster that is consistent with motivational interviewing and informed by the literature on effective interventions for our target population and targeted risk factors, or (b) a computer-delivered control + one interventionist-led phone booster condition. Computer-delivered follow-up assessments will occur at 6 weeks, 3 months, 6 months, and 12 months after the baseline assessment. Anticipated 25% of planned enrollment recruited by 5/14/2021. Anticipated 50% of planned enrollment recruited by 2/15/2022. Anticipated 75% of planned enrollment recruited by 8/15/2022. Anticipated 100% of planned enrollment recruited by 2/13/2023. Anticipated completion of primary endpoints data analyses by 6/28/2024. Anticipated reporting of results in ClinicalTrials.gov by 6/30/2025.

Interventions

BEHAVIORALStrength for U in Relationship Empowerment (SURE)

A brief computer-based intervention (one session plus one booster session) based on motivational interviewing.

BEHAVIORALAttention, time, and information matched control

A brief computer based intervention (one session plus booster session) that involves viewing of popular television shows

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
Women and Infants Hospital of Rhode Island
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

1. Pregnant women 2. Women who have had a baby in the last 12 months 3. Between the ages of 18-45 years old 4. Have reported partner abuse within the last year as measured by the Woman Abuse Screening Tool (WAST) 5. Have sought mental health treatment

Exclusion criteria

1. Cannot provide informed consent 2. Unable to understand English 3. No access to the internet or a device with internet access 4. Discomfort with internet use 5. No privacy to view a 40-minute online intervention 6. Screen positive for risk of intimate partner violence that involves severe injury or homicide 7. Screen positive for risk of spyware/stalkerware 8. At one of the two research site, study recruit is unwilling to meet for in-person study visits (if criteria 3-8 are met)

Design outcomes

Primary

MeasureTime frameDescription
Composite Abuse Scale (CAS)Baseline, 6-week follow-up, 3, 6, and 12-month follow-up.The frequency of IPV will be measured using the Composite Abuse Scale. The Composite Abuse Scale is a 30-item scale with 4 subscales that measure severe combined abuse, emotional abuse, physical abuse, and harassment. Items are scored between 0 and 5, with Never=0 and Daily=5. Scale range is from 0-150. The lower the score, the better or less victimization. Change scores will be used to estimate differences within and between groups.

Secondary

MeasureTime frameDescription
The Positive Affect and Well-being Scale (PAW)Baseline, 6-week follow-up, 3, 6, and 12-month follow-upPositive affect and well-being will be measured by using the National Institutes of Health Quality of Life in Neurological Disorders scale for Positive Affect and Well-being a computerized adaptive test 9-item scale. This scale is scored between 1 and 5, with Never=1 and Always=5. Scale range is from 9-45. Higher scores indicate higher positive affect, life satisfaction, or an overall sense of purpose and meaning. Change scores will be used to estimate differences within and between groups.
Perceived Emotional Support (PES)Baseline, 6-week follow-up, 3, 6, and 12-month follow-upPerceived emotional support will be measured using a 4-item scale developed by the Patient-Reported Outcomes Measurement Information System . Patient-Reported Outcomes Measurement Information System is a National Institutes of Health Roadmap initiative that provides precise, reliable, valid, and standardized questionnaires measuring patient-reported outcomes across the domains of physical, mental, and social health. The Patient-Reported Outcomes Measurement Information System .Emotional Support item bank specifically aims to measure perceived feelings of being cared for and valued as a person. This scale is scored between 1 and 5, with Never=1 and Always=5. Scale range is from 4-20. A higher Patient-Reported Outcomes Measurement Information System score represents increased emotional support. Change scores will be used to estimate differences within and between groups.

Other

MeasureTime frameDescription
Personal Progress Scale-Revised (PPS-R)Baseline, 6-week follow-up, 3, 6, and 12-month follow-upEmpowerment will be measured using the Personal Progress Scale-Revised for measuring skills, social supports, and resources to cope more effectively with relationship stress and trauma. The Personal Progress Scale-Revised is a 28-item scale scored between 1 and 7, with 1=Almost Never and 7=Almost Always. Scale range is from 28-196. Higher scores indicating higher empowerment. Change scores will be used to estimate differences within and between groups.
Self-efficacy (GSE)Baseline, 6-week follow-up, 3, 6, and 12-month follow-upSelf-efficacy will be measured using the General Self-Efficacy Scale a 10-item self-report measure. It measures personal competence to deal effectively with a variety of stressful situations. The General Self-Efficacy Scale is scored from 10-40, with 1=Not at all true and 4=Exactly true. A higher score indicates more self-efficacy. Change scores will be used to estimate differences within and between groups.

Countries

United States

Participant flow

Participants by arm

ArmCount
Strength for U in Relationship Empowerment (SURE)
Theory-driven and derived from empirical support Strength for U in Relationship Empowerment (SURE): A brief computer-based intervention (one session plus one booster session) based on motivational interviewing.
65
Attention, Time, and Information Matched Control
Well-validated Attention, time, and information matched control: A brief computer based intervention (one session plus booster session) that involves viewing of popular television shows
57
Total122

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up84
Overall StudyWithdrawal by Subject13

Baseline characteristics

CharacteristicStrength for U in Relationship Empowerment (SURE)Attention, Time, and Information Matched ControlTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
65 Participants57 Participants122 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
12 Participants13 Participants25 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
53 Participants44 Participants97 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Asian
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Bi-Racial or Multi-Ethnic
3 Participants3 Participants6 Participants
Race/Ethnicity, Customized
Black
13 Participants16 Participants29 Participants
Race/Ethnicity, Customized
Caucasian/White
45 Participants33 Participants78 Participants
Race/Ethnicity, Customized
Native American or Native Alaskan
2 Participants0 Participants2 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Other
1 Participants5 Participants6 Participants
Race/Ethnicity, Customized
Unknown or Not Reported
0 Participants0 Participants0 Participants
Region of Enrollment
United States
65 Participants57 Participants122 Participants
Sex: Female, Male
Female
65 Participants57 Participants122 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants
Sex/Gender, Customized
Female
65 Participants57 Participants122 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 650 / 57
other
Total, other adverse events
0 / 650 / 57
serious
Total, serious adverse events
24 / 6517 / 57

Outcome results

Primary

Composite Abuse Scale (CAS)

The frequency of IPV will be measured using the Composite Abuse Scale. The Composite Abuse Scale is a 30-item scale with 4 subscales that measure severe combined abuse, emotional abuse, physical abuse, and harassment. Items are scored between 0 and 5, with Never=0 and Daily=5. Scale range is from 0-150. The lower the score, the better or less victimization. Change scores will be used to estimate differences within and between groups.

Time frame: Baseline, 6-week follow-up, 3, 6, and 12-month follow-up.

Population: All baseline outcome measures were missing for one subject due to a software issue. As a consequence, the outcome analysis was carried out with data from 121 participants.

ArmMeasureGroupValue (MEAN)Dispersion
Strength for U in Relationship Empowerment (SURE)Composite Abuse Scale (CAS)6-month follow-up8.89 units on a scaleStandard Deviation 12.06
Strength for U in Relationship Empowerment (SURE)Composite Abuse Scale (CAS)Baseline29.13 units on a scaleStandard Deviation 20.92
Strength for U in Relationship Empowerment (SURE)Composite Abuse Scale (CAS)6-week follow-up10.54 units on a scaleStandard Deviation 12.02
Strength for U in Relationship Empowerment (SURE)Composite Abuse Scale (CAS)3-month follow-up9.69 units on a scaleStandard Deviation 10.39
Strength for U in Relationship Empowerment (SURE)Composite Abuse Scale (CAS)12-month follow-up11.45 units on a scaleStandard Deviation 14.56
Attention, Time, and Information Matched ControlComposite Abuse Scale (CAS)12-month follow-up7.5 units on a scaleStandard Deviation 12.02
Attention, Time, and Information Matched ControlComposite Abuse Scale (CAS)3-month follow-up8.27 units on a scaleStandard Deviation 11.06
Attention, Time, and Information Matched ControlComposite Abuse Scale (CAS)Baseline27.01 units on a scaleStandard Deviation 20.65
Attention, Time, and Information Matched ControlComposite Abuse Scale (CAS)6-month follow-up8.7 units on a scaleStandard Deviation 10.95
Attention, Time, and Information Matched ControlComposite Abuse Scale (CAS)6-week follow-up10.02 units on a scaleStandard Deviation 12.78
Comparison: Linear Mixed regression models (LMM) have been used to identify any difference between the intervention and the control groups over time with regards to the continuous outcomes. Group (intervention vs. control), a 5-category time (baseline, 6 week, 3 month, 6 month, 12 month) and group-by-time interaction are covariates in the model. A random subject intercept is used to account for clustering within subject.p-value: >0.05Regression, Linear
Secondary

Perceived Emotional Support (PES)

Perceived emotional support will be measured using a 4-item scale developed by the Patient-Reported Outcomes Measurement Information System . Patient-Reported Outcomes Measurement Information System is a National Institutes of Health Roadmap initiative that provides precise, reliable, valid, and standardized questionnaires measuring patient-reported outcomes across the domains of physical, mental, and social health. The Patient-Reported Outcomes Measurement Information System .Emotional Support item bank specifically aims to measure perceived feelings of being cared for and valued as a person. This scale is scored between 1 and 5, with Never=1 and Always=5. Scale range is from 4-20. A higher Patient-Reported Outcomes Measurement Information System score represents increased emotional support. Change scores will be used to estimate differences within and between groups.

Time frame: Baseline, 6-week follow-up, 3, 6, and 12-month follow-up

Population: All baseline outcome measures were missing for one subject due to a software issue. As a consequence, the outcome analysis was carried out with data from 121 participants.

ArmMeasureGroupValue (MEAN)Dispersion
Strength for U in Relationship Empowerment (SURE)Perceived Emotional Support (PES)6- Week15.41 units on a scaleStandard Deviation 3.63
Strength for U in Relationship Empowerment (SURE)Perceived Emotional Support (PES)6- Month15.15 units on a scaleStandard Deviation 3.54
Strength for U in Relationship Empowerment (SURE)Perceived Emotional Support (PES)3- Month15.75 units on a scaleStandard Deviation 3.45
Strength for U in Relationship Empowerment (SURE)Perceived Emotional Support (PES)12-Month16.02 units on a scaleStandard Deviation 3.67
Strength for U in Relationship Empowerment (SURE)Perceived Emotional Support (PES)Baseline14.61 units on a scaleStandard Deviation 4.15
Attention, Time, and Information Matched ControlPerceived Emotional Support (PES)12-Month15.58 units on a scaleStandard Deviation 4
Attention, Time, and Information Matched ControlPerceived Emotional Support (PES)Baseline14.89 units on a scaleStandard Deviation 4.16
Attention, Time, and Information Matched ControlPerceived Emotional Support (PES)6- Week15.32 units on a scaleStandard Deviation 4.23
Attention, Time, and Information Matched ControlPerceived Emotional Support (PES)3- Month14.77 units on a scaleStandard Deviation 4.46
Attention, Time, and Information Matched ControlPerceived Emotional Support (PES)6- Month15.12 units on a scaleStandard Deviation 3.49
Comparison: Statistical analysis strategy is identical to that for the primary outcome.p-value: >0.05Regression, Linear
Secondary

The Positive Affect and Well-being Scale (PAW)

Positive affect and well-being will be measured by using the National Institutes of Health Quality of Life in Neurological Disorders scale for Positive Affect and Well-being a computerized adaptive test 9-item scale. This scale is scored between 1 and 5, with Never=1 and Always=5. Scale range is from 9-45. Higher scores indicate higher positive affect, life satisfaction, or an overall sense of purpose and meaning. Change scores will be used to estimate differences within and between groups.

Time frame: Baseline, 6-week follow-up, 3, 6, and 12-month follow-up

Population: All baseline outcome measures were missing for one subject due to a software issue. As a consequence, the outcome analysis was carried out with data from 121 participants.

ArmMeasureGroupValue (MEAN)Dispersion
Strength for U in Relationship Empowerment (SURE)The Positive Affect and Well-being Scale (PAW)6-week follow-up31.68 units on a scaleStandard Deviation 6.43
Strength for U in Relationship Empowerment (SURE)The Positive Affect and Well-being Scale (PAW)6-month follow-up32.64 units on a scaleStandard Deviation 6.08
Strength for U in Relationship Empowerment (SURE)The Positive Affect and Well-being Scale (PAW)3-month follow-up33.21 units on a scaleStandard Deviation 5.91
Strength for U in Relationship Empowerment (SURE)The Positive Affect and Well-being Scale (PAW)12-month follow-up33.59 units on a scaleStandard Deviation 5.75
Strength for U in Relationship Empowerment (SURE)The Positive Affect and Well-being Scale (PAW)Baseline29.39 units on a scaleStandard Deviation 7.32
Attention, Time, and Information Matched ControlThe Positive Affect and Well-being Scale (PAW)12-month follow-up32.93 units on a scaleStandard Deviation 6.64
Attention, Time, and Information Matched ControlThe Positive Affect and Well-being Scale (PAW)Baseline29.95 units on a scaleStandard Deviation 7.17
Attention, Time, and Information Matched ControlThe Positive Affect and Well-being Scale (PAW)6-week follow-up32.05 units on a scaleStandard Deviation 6.68
Attention, Time, and Information Matched ControlThe Positive Affect and Well-being Scale (PAW)3-month follow-up31.4 units on a scaleStandard Deviation 6.84
Attention, Time, and Information Matched ControlThe Positive Affect and Well-being Scale (PAW)6-month follow-up30.84 units on a scaleStandard Deviation 6.51
Comparison: Statistical analysis strategy is identical to that for the primary outcome.p-value: >0.05Regression, Linear
Other Pre-specified

Personal Progress Scale-Revised (PPS-R)

Empowerment will be measured using the Personal Progress Scale-Revised for measuring skills, social supports, and resources to cope more effectively with relationship stress and trauma. The Personal Progress Scale-Revised is a 28-item scale scored between 1 and 7, with 1=Almost Never and 7=Almost Always. Scale range is from 28-196. Higher scores indicating higher empowerment. Change scores will be used to estimate differences within and between groups.

Time frame: Baseline, 6-week follow-up, 3, 6, and 12-month follow-up

Population: All baseline outcome measures were missing for one subject due to a software issue. As a consequence, the outcome analysis was carried out with data from 121 participants.

ArmMeasureGroupValue (MEAN)Dispersion
Strength for U in Relationship Empowerment (SURE)Personal Progress Scale-Revised (PPS-R)6-Week109.08 units on a scaleStandard Deviation 14.39
Strength for U in Relationship Empowerment (SURE)Personal Progress Scale-Revised (PPS-R)6-Month111.42 units on a scaleStandard Deviation 14.01
Strength for U in Relationship Empowerment (SURE)Personal Progress Scale-Revised (PPS-R)3-Month111.4 units on a scaleStandard Deviation 13.4
Strength for U in Relationship Empowerment (SURE)Personal Progress Scale-Revised (PPS-R)12-Month114.1 units on a scaleStandard Deviation 16.44
Strength for U in Relationship Empowerment (SURE)Personal Progress Scale-Revised (PPS-R)Baseline129.53 units on a scaleStandard Deviation 21.66
Attention, Time, and Information Matched ControlPersonal Progress Scale-Revised (PPS-R)12-Month110.87 units on a scaleStandard Deviation 12.03
Attention, Time, and Information Matched ControlPersonal Progress Scale-Revised (PPS-R)Baseline132.56 units on a scaleStandard Deviation 22.62
Attention, Time, and Information Matched ControlPersonal Progress Scale-Revised (PPS-R)6-Week113.66 units on a scaleStandard Deviation 11.72
Attention, Time, and Information Matched ControlPersonal Progress Scale-Revised (PPS-R)3-Month113.74 units on a scaleStandard Deviation 14.11
Attention, Time, and Information Matched ControlPersonal Progress Scale-Revised (PPS-R)6-Month113.84 units on a scaleStandard Deviation 14.11
Comparison: Statistical analysis strategy is identical to that for primary outcome.p-value: >0.05Regression, Linear
Other Pre-specified

Self-efficacy (GSE)

Self-efficacy will be measured using the General Self-Efficacy Scale a 10-item self-report measure. It measures personal competence to deal effectively with a variety of stressful situations. The General Self-Efficacy Scale is scored from 10-40, with 1=Not at all true and 4=Exactly true. A higher score indicates more self-efficacy. Change scores will be used to estimate differences within and between groups.

Time frame: Baseline, 6-week follow-up, 3, 6, and 12-month follow-up

Population: All baseline outcome measures were missing for one subject due to a software issue. As a consequence, the outcome analysis was carried out with data from 121 participants.

ArmMeasureGroupValue (MEAN)Dispersion
Strength for U in Relationship Empowerment (SURE)Self-efficacy (GSE)6- Week28.71 units on a scaleStandard Deviation 4.17
Strength for U in Relationship Empowerment (SURE)Self-efficacy (GSE)6- Month29.49 units on a scaleStandard Deviation 4.23
Strength for U in Relationship Empowerment (SURE)Self-efficacy (GSE)3- Month29.67 units on a scaleStandard Deviation 3.82
Strength for U in Relationship Empowerment (SURE)Self-efficacy (GSE)12-Month30.72 units on a scaleStandard Deviation 3.94
Strength for U in Relationship Empowerment (SURE)Self-efficacy (GSE)Baseline28.45 units on a scaleStandard Deviation 4.57
Attention, Time, and Information Matched ControlSelf-efficacy (GSE)12-Month29.79 units on a scaleStandard Deviation 4.7
Attention, Time, and Information Matched ControlSelf-efficacy (GSE)Baseline27.34 units on a scaleStandard Deviation 4.8
Attention, Time, and Information Matched ControlSelf-efficacy (GSE)6- Week28.68 units on a scaleStandard Deviation 5.23
Attention, Time, and Information Matched ControlSelf-efficacy (GSE)3- Month29.57 units on a scaleStandard Deviation 5.32
Attention, Time, and Information Matched ControlSelf-efficacy (GSE)6- Month28.84 units on a scaleStandard Deviation 4.58
Comparison: Statistical Analysis strategy is identical to that for primary outcome measure.p-value: >0.05Regression, Linear

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026